![René Vleugels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. René Vleugels is a Chief Executive Officer at CyTuVax BV and a Co-Founder at NovoVacs BV.
Dr. Vleugels was previously employed as a Founder by AdjuTec BV, a Managing Director by MUbio Holding BV, and a Principal by Maastricht University.
He received his doctorate degree from Radboud University Nijmegen.
Aktive Positionen von René Vleugels
| Unternehmen | Position | Beginn |
|---|---|---|
NovoVacs BV | Gründer | 01.09.2009 |
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology Develops vaccinations for cancer treatment | Vorstandsvorsitzender | 01.01.2011 |
Ehemalige bekannte Positionen von René Vleugels
| Unternehmen | Position | Ende |
|---|---|---|
Maastricht University
 Maastricht University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
AdjuTec BV
 AdjuTec BV Pharmaceuticals: MajorHealth Technology Manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients | Gründer | - |
MUbio Holding BV
 MUbio Holding BV BiotechnologyHealth Technology Develops and manufactures antibody reagents for cell biology and biomedical research including cancer and stem cell research | Gründer | - |
Ausbildung von René Vleugels
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Maastricht University
Maastricht University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MUbio Holding BV
MUbio Holding BV BiotechnologyHealth Technology Develops and manufactures antibody reagents for cell biology and biomedical research including cancer and stem cell research | Health Technology |
NovoVacs BV | |
CyTuVax BV
CyTuVax BV Pharmaceuticals: MajorHealth Technology Develops vaccinations for cancer treatment | Health Technology |
AdjuTec BV
AdjuTec BV Pharmaceuticals: MajorHealth Technology Manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients | Health Technology |
